Prehypertension.
Conditions
Interventions
Intervention 1: The intervention group: In this group, a capsule containing 26 mg of the active constituents gingerol is used at a daily dose of 1 capsule for 2 months (After purchasing the gingerol s
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients who have received a diagnosis of hypertension within the maximum last three months. Patient consent to enter the study. The age of the patients is between 30 and 70 years.
Exclusion criteria
Exclusion criteria: Patients with diabetes. Patients with high blood pressure. Patients with blood disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic and diastolic blood pressure (main variable). Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Mercury sphygmomanometer.;Cholesterol. Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Chemistry Analyzer.;Triglycerides. Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Chemistry Analyzer.;Low Density Lipoprotein (LDL). Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Chemistry Analyzer.;Nitric oxide metabolites. Timepoint: At the beginning of the study (before intervention) and 4, 8 weeks after the start of taking ginger capsules. Method of measurement: Nitric oxide assay kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Beiranvand
Khoram-Abad University of Medical Sciences
Outcome results
None listed